Status:
UNKNOWN
Potential Role of Intravenous Lidocaine Versus Intravenous Ketamine for Pain Management in Fibromyalgia Patients
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia
Eligibility:
All Genders
25-50 years
Phase:
PHASE4
Brief Summary
The aim of the study is to assess the efficacy of intravenous lidocaine versus intravenous ketamine in treatment of fibromyalgia patients.
Detailed Description
Adult fibromyalgia patients (25 to 50 years old) suffering from with uncontrolled pain perception will be enrolled although maximum medical treatment is prescribed. Pre-procedure study tools: * pati...
Eligibility Criteria
Inclusion
- Patients with FM, diagnosed according to the American College of Rheumatology (ACR) 2016 diagnostic criteria for FM. (Wolfe, F., Clauw, D. J., Fitzcharles, M. A., et al., 2016)
Exclusion
- \- Known hypersensitivity to any of the given drugs or one of their derivatives (lidocaine or ketamine).
- Known Arrhythmia (Supraventricular or ventricular).
- Pregnant females.
Key Trial Info
Start Date :
September 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06184958
Start Date
September 2 2023
End Date
March 1 2024
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
maha sadek El Derh
Cairo, Egypt, 11721